Association of long-term nicotine abstinence with normal metabotropic glutamate receptor-5 binding

Akkus, Funda; Treyer, Valerie; Johayem, Anass; Ametamey, Simon M; Mancilla, Baltazar Gomez; Sovago, Judit; Buck, Alfred; Hasler, Gregor (2016). Association of long-term nicotine abstinence with normal metabotropic glutamate receptor-5 binding. Biological psychiatry, 79(6), pp. 474-480. Elsevier 10.1016/j.biopsych.2015.02.027

	Text Akkus_Hasler_2015_nicotine_mGluR5_long-term_abstinence.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (186kB) | Request a copy
Preview	Text Long_Ex_Smoker_mGluR5_publ_unmarked.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (116kB) | Preview

BACKGROUND

Nicotine addiction is a major public health problem and is associated with primary glutamatergic dysfunction. We recently showed marked global reductions in metabotropic glutamate receptor type 5 (mGluR5) binding in smokers and recent ex-smokers (average abstinence duration of 25 weeks). The goal of this study was to examine the role of mGluR5 downregulation in nicotine addiction by investigating a group of long-term ex-smokers (abstinence >1.5 years), and to explore associations between mGluR5 binding and relapse in recent ex-smokers.

METHODS

Images of mGluR5 receptor binding were acquired in 14 long-term ex-smokers, using positron emission tomography with radiolabeled [11C]ABP688, which binds to an allosteric site with high specificity.

RESULTS

Long-term ex-smokers and individuals who had never smoked showed no differences in mGluR5 binding in any of the brain regions examined. Long-term ex-smokers showed significantly higher mGluR5 binding than recent ex-smokers, most prominently in the frontal cortex (42%) and thalamus (57%).

CONCLUSIONS

Our findings suggest that downregulation of mGluR5 is a pathogenetic mechanism underlying nicotine dependence and the high relapse rate in individuals previously exposed to nicotine. Therefore, mGluR5 receptor binding appears to be an effective biomarker in smoking and a promising target for the discovery of novel medication for nicotine dependence and other substance-related disorders.

Interest & Impact

Downloads

452 since deposited on 07 Jan 2016
52 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item